Literature DB >> 33478568

The pterional approach for the surgical resection of an orbital cholesteatoma: a case report.

Parménides Guadarrama-Ortiz1, José Alberto Choreño-Parra2, Francisco Javier Pacheco-Sánchez2,3, Alberto Iván Rodríguez-Nava2,3, Gabriela García-Quintero2,3, Patricia Emilia Rodríguez-Muñoz2, Carlos Sánchez-Garibay4, Manuel Ángeles-Castellanos5.   

Abstract

BACKGROUND: Cholesteatomas are benign tumors mainly composed of cholesterol crystals that rarely arise within the orbit. However, orbital cholesteatomas require a complete surgical resection due to their recidivating potential. Transcranial approaches offering a broad surgical exposure of the orbital cavity have been scarcely used for the management of these tumors. Here, we provide evidence of the benefits of the pterional craniotomy for the surgical resection of orbital tumors by sharing our experience in the surgical management of a cholesteatoma of the superotemporal orbital wall. CASE
PRESENTATION: A 45-year-old Hispanic man with a 2-year history of progressive proptosis of the left eye attended to our center complaining of diplopia and migraine. At his arrival, physical examination revealed ptosis, palpebral edema, and exophthalmos of the left eye, as well as the abolishment of the ipsilateral photomotor and consensual responses. Fundoscopy showed mild optic atrophy, whereas a T2-weighted magnetic resonance imaging (MRI) of the head showed a hyperintense mass arising at the superotemporal wall of the orbit that was displacing the eyeball. The tumor was resected using a pterional craniotomy without postoperative complications. The histopathological analysis of the tumor revealed a cholesteatoma. The patient recovered the functionality of the left eye with no visual sensitive deficits nor tumor recurrence 1 year after the surgery.
CONCLUSIONS: Our results support the use of the pterional craniotomy as a safe procedure for the surgical resection of cholesteatomas arising at the superotemporal walls of the orbit, with low postoperative morbidity.

Entities:  

Keywords:  Cholesteatoma; Cholesterol granuloma; Neurosurgery; Ocular surgery; Orbital tumors; Pterional approach

Mesh:

Year:  2021        PMID: 33478568      PMCID: PMC7821492          DOI: 10.1186/s13256-020-02579-3

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  8 in total

1.  Epidemiology of orbital disease.

Authors:  Carlo De Conciliis
Journal:  Ophthalmology       Date:  2003-07       Impact factor: 12.079

2.  Pterional/Lateral approach to orbital tumors.

Authors:  J M Gilsbach; W J Mann; R Rochels; R G Amedee; W Lieb; G Laborde
Journal:  Skull Base Surg       Date:  1994

3.  Microsurgical pterional approach to aneurysms of the basilar bifurcation.

Authors:  M G Yasargil; J Antic; R Laciga; K K Jain; R M Hodosh; R D Smith
Journal:  Surg Neurol       Date:  1976-08

4.  A neurosurgical perspective to approaches to the orbit: A cadaveric study.

Authors:  S Balaji Pai; M N Nagarjun
Journal:  Neurol India       Date:  2017 Sep-Oct       Impact factor: 2.117

Review 5.  Orbitofrontal Cholesterol Granuloma: Four Case Reports and a Systematic Review of the English Literature.

Authors:  Joshua D Hughes; Jeffery T Jacob; James A Garrity; Diva R Salomao; Michael J Link
Journal:  World Neurosurg       Date:  2015-12-24       Impact factor: 2.104

Review 6.  An analysis of 2,480 space-occupying lesions of the orbit from 1976 to 2011.

Authors:  Giulio Bonavolontà; Diego Strianese; Piergiacomo Grassi; Chiara Comune; Fausto Tranfa; Giovanni Uccello; Adriana Iuliano
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2013 Mar-Apr       Impact factor: 1.746

7.  Orbital cholesterol granuloma and cholesteatoma: significance of differentiating the two.

Authors:  David R Jordan; Peter Spitellie; Seymour Brownstein; Nigel Rawlings; Steven M Gilberg
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2007 Sep-Oct       Impact factor: 1.746

8.  'Cholesteatoma' of the orbit.

Authors:  D W Parke; R L Font; M Boniuk; J A McCrary
Journal:  Arch Ophthalmol       Date:  1982-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.